Rp Management, LLC Biohaven Pharmaceutical Holding CO Ltd. Transaction History

Rp Management, LLC

2 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q2 2021 Aug 12, 2021	SELL	$65.78 - $105.02 $65.8 Million - $105 Million	-1,000,000 Reduced 47.37%	1,111,111 $108 Million
Q4 2018 Feb 14, 2019	BUY	$29.75 - $42.9 $62.8 Million - $90.6 Million	2,111,111 New	2,111,111 $78.1 Million

785K

Ticker BHVN
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 71,645,000
Market Cap $3.65B
Description
Biohaven Pharmaceutical Holding Company Ltd., a biopharmaceutical company, develops products candidates targeting neurological and neuropsychiatric diseases, and rare disorders in the United States. It offers NURTEC ODT (rimegepant) for the acute treatment of migraine, as well as developing Rimegepant for preventive treatment of migraine; Zavege...

Get notified when there are updates to the investment portfolio of Rp Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Rp Management, LLC with notifications on news.